Dyslipidemia, statins and prostate cancer
Authors:
- Kevin R RiceKRKevin R Rice
- Michael O KochMKMichael O Koch
- Liang ChengLCLiang Cheng
- Timothy A MastersonTMTimothy A Masterson
- 1 July 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 12 (7) , 981-990
Abstract
Dyslipidemia and prostate cancer are two of the most common medical conditions affecting adult males in the USA. In recent years, a large volume of research has focused on investigating the relationship between these two disease processes as well as the effect of the cholesterol-lowering medications, such as 3-hydroxyl-3-methylglutaryl-coenzyme A reductase inhibitors (better known as 'statins'), on the development and progression of prostate cancer. While there is a paucity of prospective research, encouraging results have been reported in several retrospective clinical studies. Additionally, basic science research has identified interactions between lipids and prostate cancer cells in several key areas. This article will discuss recent clinical and basic science research examining the relationship between dyslipidemia, statins and prostate cancer.Keywords
This publication has 66 references indexed in Scilit:
- Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: A simulation studyCancer Epidemiology, 2011
- Statin medication use and the risk of biochemical recurrence after radical prostatectomyCancer, 2010
- Cholesterol Sulfate Imaging in Human Prostate Cancer Tissue by Desorption Electrospray Ionization Mass SpectrometryAnalytical Chemistry, 2010
- Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004Cancer Causes & Control, 2010
- Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohortCancer Causes & Control, 2009
- Serum triglyceride concentrations and cancer risk in a large cohort study in AustriaBritish Journal of Cancer, 2009
- Association between plasma cholesterol and prostate cancer in the PSA eraInternational Journal of Cancer, 2008
- Statin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic StudyAmerican Journal of Epidemiology, 2008
- Statin use and prostate cancer risk in a large population-based settingCancer Causes & Control, 2008
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI: Journal of the National Cancer Institute, 2008